REPORT/RECOMMENDATION TO THE BOARD OF SUPERVISORS
OF SAN BERNARDINO COUNTY
AND RECORD OF ACTION
April 23, 2024
FROM
WILLIAM L. GILBERT, Director, Arrowhead Regional Medical Center
SUBJECT
Title
Encompass Agreement with Roche Diagnostics Corporation for Software Equipment, Services, Reagent, and Supplies
End
RECOMMENDATION(S)
Recommendation
Approve Encompass Agreement with Roche Diagnostic Corporation for blood glucose testing software, equipment, services, reagents, and supplies, in an amount not to exceed $686,215 for the contract term of April 23, 2024 through April 22, 2029.
(Presenter: William L. Gilbert, 580-6150)
Body
COUNTY AND CHIEF EXECUTIVE OFFICER GOALS & OBJECTIVES
Provide for the Safety, Health and Social Service Needs of County Residents.
FINANCIAL IMPACT
Approval of the item will not result in the use of Discretionary General Funding (Net County Cost). The cost of $686,215 is funded by State Medi-Cal, Federal Medicare, private insurances, and other departmental revenue. Funding sources may change in the future pending any legislative activity related to the repeal and/or replacement of the Affordable Care Act. Adequate appropriation and revenue have been included in the Arrowhead Regional Medical Center (ARMC) 2023-24 budget and will be included in future recommended budgets.
BACKGROUND INFORMATION
The Encompass Agreement (Agreement) with Roche Diagnostic Corporation (Roche) will allow ARMC to provide a simple testing system for its patients that monitors the blood glucose level at the bedside. This testing is necessary for ARMC clinicians to assess and treat patients in a timely manner.
ARMC first acquired Roche Accuchek Inform II (Accuchek) testing equipment in 2013. The Accuchek equipment has provided excellent quality and reliability and is user friendly with an easy to operate design. It uses a quick fill reagent test strip that requires a very small blood sample and provides results in five seconds.
The Agreement will provide for equipment, supplies, reagents and service for the performance of bedside blood glucose testing and will allow ARMC to continue to use equipment already in place. In addition, this Agreement allows ARMC to use the Abbott Remote Automated Laboratory System Remote Connect and Epic Laboratory Information System interface previously purchased and installed. On February 12, 2019 (Item No. 11), the Board of Supervisors approved Contract No. 19-79 with Roche Diagnostic Corporation in the amount of $565,921 for the period of April 8, 2019 through April 7, 2024, for blood glucose testing equipment, supplies, reagents, and services.
ARMC recommends approval of the Agreement to provide for the safety, health and social needs of county residents by ensuring that ARMC is able to maintain its equipment with the most updated software, continue its high-quality service levels, and obtain supplies to administer to its patients.
PROCUREMENT
The Purchasing Department supports this non-competitive procurement based on functional specifications and integration into current hospital systems. This Agreement will continue to provide bedside blood glucose testing, which will allow ARMC to use the glucose equipment already purchased and in place.
REVIEW BY OTHERS
This item has been reviewed by County Counsel (Bonnie Uphold, Supervising Deputy County Counsel, 387-5455) on March 28, 2024; Purchasing (Veronica Pedace, Buyer, 387-2464) on March 28, 2024; ARMC Finance (Chen Wu, Finance and Budget Officer, 580-3165) on April 1, 2024; Finance (Jenny Yang, Administrative Analyst, 387-4884) on April 3, 2024; and County Finance and Administration (Valerie Clay, Deputy Executive Officer, 387-5423) on April 4, 2024.